P117: Comparison between calprotectin and HMGB1 as faecal biomarkers of intestinal inflammation in paediatric and adult inflammatory bowel diseaseECCO '16 Amsterdam
2016
P120: Faecal calprotectin and S100A12 detect the early response to treatment by quantifying colonic inflammation in patients with ulcerative colitisECCO '16 Amsterdam
2016
P121: Patients’ point of view regarding acceptability and usefulness of inflammatory bowel diseases monitoring tools: results from a nationwide multicentre study (the ACCEPT study)ECCO '16 Amsterdam
2016
P122: Role of diffusion-weighted imaging in MRI-enterography for the evaluation of surgical risk in patients with Crohn’s diseaseECCO '16 Amsterdam
2016
P123: Significance of serological markers in the disease course of ulcerative colitisECCO '16 Amsterdam
2016
P124: Systematic review of the impact of psychological morbidity and associated risk factors in young people with inflammatory bowel diseaseECCO '16 Amsterdam
2016
P125: Investigating the small bowel in paediatric Crohn’s disease: prospective comparative study between small intestine contrast ultrasonography and magnetic resonance imagingECCO '16 Amsterdam
2016
P126: IBD-related malignancies and mortalities observed in 2015: first results from the prospective nationwide Hungarian registryECCO '16 Amsterdam
2016
P127: Predictive role of penetrating disease behaviour, ileal localisation, female gender, and plexitis in the postoperative recurrence of Crohn’s diseaseECCO '16 Amsterdam
2016
P128: Faecal calprotectin has an acceptable sensitivity for detecting small bowel Crohn’s disease: results from real-world clinical practiceECCO '16 Amsterdam
2016
P129: Factors associated with anxiety and depression in Korean inflammatory bowel disease patientsECCO '16 Amsterdam
2016
P130: Anxiety and depression may lead to poor health-related quality of life in patients with inflammatory bowel diseaseECCO '16 Amsterdam
2016
P131: Predicting early endoscopic recurrence after ileocolic resection for Crohn’s diseaseECCO '16 Amsterdam
2016
P133: Usefulness of magnetic resonance enterography on medical decision making in patients with inflammatory bowel disease after a 1-year
follow-upECCO '16 Amsterdam
2016
P134: Illness perceptions and outcomes in patients with inflammatory bowel disease: is coping a mediator?ECCO '16 Amsterdam
2016
P135: Serum Chitinase 3-like-1 (CHI3L1) and faecal calprotectin levels for non-invasive disease activity assessment in inflammatory bowel disease patients during pregnancyECCO '16 Amsterdam
2016
P136: Validation of ulcerative colitis endoscopic index of severity (UCEIS) in KoreaECCO '16 Amsterdam
2016